EOLIA trial: the future of extracorporeal membrane oxygenation in acute respiratory distress syndrome therapy?

Breathe (Sheff). 2019 Sep;15(3):244-246. doi: 10.1183/20734735.0363-2018.


In the EOLIA trial, early use of ECMO did not significantly improve mortality at 60 days in patients with severe ARDS, but when used as a rescue modality ECMO might help improve survival http://bit.ly/2XOjwSE.